Minzasolmin

CAS No. 1802518-92-8

Minzasolmin( —— )

Catalog No. M35629 CAS No. 1802518-92-8

Minzasolmin(DLX-313) is an alpha-synuclein misfolding inhibitor for the study of Parkinson's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 424 Get Quote
5MG 644 Get Quote
10MG 1036 Get Quote
25MG 1822 Get Quote
50MG 3064 Get Quote
100MG 4797 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Minzasolmin
  • Note
    Research use only, not for human use.
  • Brief Description
    Minzasolmin(DLX-313) is an alpha-synuclein misfolding inhibitor for the study of Parkinson's disease.
  • Description
    Minzasolmin is an alpha-synuclein oligomerization inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1802518-92-8
  • Formula Weight
    425.59
  • Molecular Formula
    C23H31N5OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C([C@H](NC(=O)C=1SC(=NC1)N2CCN(C)CC2)CCCC)C=3C=4C(NC3)=CC=CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 35, No. 4, 2021.
molnova catalog
related products
  • N'-Methylnicotinamid...

    N-methylnicotinamide is a metabolite of niacin (or nicotinamide) and is commonly found in human urine. However low levels of urinary excretion of N-methylnicotinamide indicates niacin deficiency. In patients with liver cirrhosis nicotinamide methylation is increased leading to a rise in urinary N-methylnicotinamide. N-methylnicotinamide has been found to be a microbial metabolite.

  • GLP-1(7-36)

    GLP-1 (7-36) amide is a peptide hormone released from intestinal L-cells upon nutrient consumption.

  • Hydroxocobalamin

    Hydroxocobalamin (Standard) is the analytical standard of Hydroxocobalamin. This product is intended for research and analytical applications. Hydroxocobalamin (Vitamin B12a) is an injectable naturally occurring form of vitamin B12 with a favorable adverse effect profile, used as a dietary supplement in the treatment of vitamin B12 deficiency including pernicious anemia.